Team:SYSU-China/Project/Results
From 2013.igem.org
Sympathetic (Talk | contribs) |
|||
(19 intermediate revisions not shown) | |||
Line 5: | Line 5: | ||
<style type="text/css"> | <style type="text/css"> | ||
body {background-color:#aaab4d;} | body {background-color:#aaab4d;} | ||
- | #cont_column h1 {color: # | + | #cont_column h1,#cont_column h2,#cont_column h3 {color: #81822f;} |
- | #cont_column | + | #cont_column h3 {border-bottom: 2px solid #aaab4d;} |
- | #cont_column | + | #cont_column p,#cont_column li {color: #1d1d02;} |
- | table {color:# | + | table {color:#1d1d02;background-color:transparent;} |
</style> | </style> | ||
Line 23: | Line 23: | ||
</head> | </head> | ||
<body> | <body> | ||
+ | <div id="outerdiv" style="position:fixed;top:0;left:0;background:rgba(220,220,220,0.9);z-index:2;width:100%;height:100%;display:none;"><div id="innerdiv" style="position:absolute;"><img id="bigimg" style="border:5px solid #fff;" src="" /></div></div> | ||
<DIV id="animat"> | <DIV id="animat"> | ||
<span><p>ipsc</p> | <span><p>ipsc</p> | ||
Line 33: | Line 34: | ||
<!--正 文 部 分 开 始--> | <!--正 文 部 分 开 始--> | ||
<DIV class="chapter"> | <DIV class="chapter"> | ||
- | <span> | + | <span>Project/Results</span> |
- | <h1>Overview of | + | <h1>Overview of Results</h1> |
- | + | <p>Our experimental results are presented by two lines. One is the <strong>test for each part</strong>, the other is the <strong>test in each period of cells</strong>. </p> | |
+ | <h2><a href="https://2013.igem.org/Team:SYSU-China/Project/Result/element_test?#button02">Test for each part </a></h2> | ||
<p> | <p> | ||
- | + | Our iPSC safeguard device consists of three parts: the killer (suicide gene), the sensor (miR-122 binding site) and the switch (Tet-off system). Candidates of each part were cloned and characterized. For Suicide Gene, RIP1 and RIP3 has optimal lethal effect in both HEK293 and HepG2 while apoptin can only kill HepG2. MiR-122 target can sensitively regulate gene expression as GFP level negatively correlates with exogenous level of miR-122 transected to HEK293. Tet-off system with pTight and tTA shows a low leakage expression level and medium full expression level. Differential equations were employed to analyze and predict the performance of the pathway.</p> | |
- | <p><strong>If you want to see the results, please click the following wheer gears.</strong></p> | + | <p><strong>If you want to see the results for testing each parts, please click the following wheer gears.</strong></p> |
- | < | + | <div class="results_guide"> |
+ | <a class="guide_button" id="target" href="https://2013.igem.org/Team:SYSU-China/Project/Result/element_test?#button02"></a> | ||
+ | <a class="guide_button" id="suicidegene" href="https://2013.igem.org/Team:SYSU-China/Project/Result/element_test?#button01"></a> | ||
+ | <a class="guide_button" id="tet-off" href="https://2013.igem.org/Team:SYSU-China/Project/Result/element_test?#button03"></a> | ||
+ | <a class="guide_button" id="lenti-virus" href="https://2013.igem.org/Team:SYSU-China/Project/Result/element_test?#button04"></a> | ||
+ | </div> | ||
Line 45: | Line 52: | ||
+ | <h2><a href="https://2013.igem.org/Team:SYSU-China/Project/result/stable_assay?#button01">Test in different cells</a> </h2> | ||
<p> | <p> | ||
- | After | + | After prove of function, the pathway was packaged into lentivirus to test the performance in our three destiny cell types: iPSCs, hepatocytes and hepatomas. So far, we have successfully generated Oct4-GFP miPSCs with pluripotency verified. All three suicide genes have significant lethal effects in iPSCs and HepG2. With pathway integrated into the genome by lentivirus, leakage expression of TRE3G is low enough to be safe, but the pTight does not work well. Doxycycline has no obvious side effects to iPSC. Stable cell line with both TRE3G and tTA requires a little more time to finish the second round of selection and we are still waiting for result of teratoma formation from our stable iPSCs. |
</p> | </p> | ||
- | <p><strong>If you want to see the results, please click the following cute cells.</strong></p> | + | <p><strong>If you want to see the results testing iPSCs in different periods, please click the following cute cells.</strong></p> |
- | < | + | <div class="results_guide2"> |
+ | <a class="guide_button2" id="ips" href="https://2013.igem.org/Team:SYSU-China/Project/result/stable_assay?#button01"></a> | ||
+ | <a class="guide_button2" id="hepatocyte" href="https://2013.igem.org/Team:SYSU-China/Project/result/stable_assay?#button02"></a> | ||
+ | <a class="guide_button2" id="hepatoma" href="https://2013.igem.org/Team:SYSU-China/Project/result/stable_assay?#button03"></a> | ||
+ | </div> | ||
</DIV> | </DIV> |
Latest revision as of 03:36, 29 October 2013
ipsc
Overview of Results
Our experimental results are presented by two lines. One is the test for each part, the other is the test in each period of cells.
Test for each part
Our iPSC safeguard device consists of three parts: the killer (suicide gene), the sensor (miR-122 binding site) and the switch (Tet-off system). Candidates of each part were cloned and characterized. For Suicide Gene, RIP1 and RIP3 has optimal lethal effect in both HEK293 and HepG2 while apoptin can only kill HepG2. MiR-122 target can sensitively regulate gene expression as GFP level negatively correlates with exogenous level of miR-122 transected to HEK293. Tet-off system with pTight and tTA shows a low leakage expression level and medium full expression level. Differential equations were employed to analyze and predict the performance of the pathway.
If you want to see the results for testing each parts, please click the following wheer gears.
Test in different cells
After prove of function, the pathway was packaged into lentivirus to test the performance in our three destiny cell types: iPSCs, hepatocytes and hepatomas. So far, we have successfully generated Oct4-GFP miPSCs with pluripotency verified. All three suicide genes have significant lethal effects in iPSCs and HepG2. With pathway integrated into the genome by lentivirus, leakage expression of TRE3G is low enough to be safe, but the pTight does not work well. Doxycycline has no obvious side effects to iPSC. Stable cell line with both TRE3G and tTA requires a little more time to finish the second round of selection and we are still waiting for result of teratoma formation from our stable iPSCs.
If you want to see the results testing iPSCs in different periods, please click the following cute cells.
Sun Yat-Sen University, Guangzhou, China
Address: 135# Xingang Rd.(W.), Haizhu Guangzhou, P.R.China